Portal:CPTAC

From WikiPathways

Jump to: navigation, search

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Hepatocyte growth factor receptor signaling (Homo sapiens)

Hepatocyte growth factor receptor signaling
Hepatocyte growth factor receptor signaling
Evading growth suppressors

Cell cycle (Homo sapiens)

Cell cycle
Cell cycle
Activating invasion and metastasis

Integrin-mediated cell adhesion (Homo sapiens)

Integrin-mediated cell adhesion
Integrin-mediated cell adhesion
Enabling replicative immortality

lncRNA in canonical Wnt signaling and colorectal cancer (Homo sapiens)

lncRNA in canonical Wnt signaling and colorectal cancer
lncRNA in canonical Wnt signaling and colorectal cancer
Inducing angiogenesis

Angiogenesis (Homo sapiens)

Angiogenesis
Angiogenesis
Resisting cell death

PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Homo sapiens)

PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer
PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer
Deregulating cellular energetics

Fatty acid beta-oxidation (Homo sapiens)

Fatty acid beta-oxidation
Fatty acid beta-oxidation
Genome instability and mutation

Non-homologous end joining (Homo sapiens)

Non-homologous end joining
Non-homologous end joining
Tumor promoting inflammation

IL6 signaling (Homo sapiens)

IL6 signaling
IL6 signaling
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Interferon type I signaling
Interferon type I signaling
Therapeutics

lncRNA-mediated mechanisms of therapeutic resistance (Homo sapiens)

lncRNA-mediated mechanisms of therapeutic resistance
lncRNA-mediated mechanisms of therapeutic resistance

edit  

Featured Pathways

edit  

Assay Portal

CPTAC also includes an Assay Portal to widely disseminate highly characterized proteomic assays to the global research community, with access to SOPs, reagents, and assay characterization/validation data

Resources

Learn how they incorpated WikiPathways images with custom links on their site.

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools